CVS Group (LON:CVSG)‘s stock had its “hold” rating reissued by Peel Hunt in a research report issued to clients and investors on Thursday. They currently have a GBX 1,350 ($18.08) price objective on the stock. Peel Hunt’s target price indicates a potential upside of 33.66% from the company’s current price.

CVS Group (LON CVSG) traded down GBX 282 ($3.78) during midday trading on Thursday, reaching GBX 1,010 ($13.53). 1,591,355 shares of the company’s stock traded hands, compared to its average volume of 192,270. CVS Group has a 1 year low of GBX 13.22 ($0.18) and a 1 year high of GBX 1,500 ($20.09).

CVS Group (LON:CVSG) last posted its earnings results on Friday, September 29th. The company reported GBX 42.80 ($0.57) EPS for the quarter, topping the consensus estimate of GBX 42.30 ($0.57) by GBX 0.50 ($0.01). CVS Group had a net margin of 3.65% and a return on equity of 12.22%. The firm had revenue of £271.80 million during the quarter.

WARNING: “Peel Hunt Reaffirms “Hold” Rating for CVS Group (CVSG)” was posted by American Banking News and is the property of of American Banking News. If you are reading this report on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/11/30/peel-hunt-reaffirms-hold-rating-for-cvs-group-cvsg.html.

CVS Group Company Profile

CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals.

Receive News & Ratings for CVS Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group plc and related companies with MarketBeat.com's FREE daily email newsletter.